Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis

Chinese Journal of Traumatology - English Edition

Volumn 13, Issue 3, 2010, Pages 188-192

  Zhang, Yu Bing ^a   Li, Wen ^a   Yao, Li Qing ^a   Zhao, Xue Ling ^a   Wang, Bing ^a   Li, Hong Kun ^a   Ning, Ya ^a   Song, En ^a   Zhang, Xin Xin ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Genes; Matrix metalloproteinases; Rats; Venous thrombosis; Wounds and injuries

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMORAL VEIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA EXTRACTION; THROMBUS; VASCULAR TISSUE; ANIMAL; COMPLICATION; DISEASE MODEL; ENZYMOLOGY; INJURY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VENOUS THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; VENOUS THROMBOSIS; WOUNDS AND INJURIES;

EID: 84927565670     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1008-1275.2010.03.011     Document Type: Article

References (21)

1. Henke PK, Pearce CG, Moaveni DM, et al. Targeted deletion of CCR2 impairs deep vein thrombosis resolution in a mouse mode. J Immunol 2006:177(5):3388- 3397.
2. Martini CH, Brandts A, de Bruijne EL, et al. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen level, clot lysis time and the risk of venous thrombosis. Br J Haematol 2006;134(1):92-94.
3. Zhang CQ, Huang H, Zhao Z, et al. Gene expression profile related to inflammation in rat model of traumatic deep vein thrombosis. Chin J Traumatol 2007;10(4):206-212.
4. Takahara M, Naruse T, Takagi M, et al. Matrix metalloproteinase-9 expression, tartrate-resistant acid phosphatase activity, and DNA fragmentation in vascular and cellular invasion into cartilage preceding primary endochondral ossification in long bones. J Orthop Res 2004;22(5):1050-1057. (Pubitemid 39145122)
5. Funayama H, Ishikawa SE, Kubo N, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction. Circ J 2004;68(5): 451-454. (Pubitemid 38657534)
6. Wu CY, Hsieh HL, Jou MJ, et al. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 2004;90(6):1477-1488.
7. Wu JJ, Eyre DR. Identification of hydroxypyridinium cross-linking sites in type II collagen of bovine articular cartilage. Biochemistry 1984;23(8):1850-1857.
8. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370(6484):61-65. (Pubitemid 24216953)
9. Honda M, Mori M, Ueo H, et al. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 1996;39(3):444-448. (Pubitemid 26338536)
10. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378(3-4):151-160.
11. Rechardt O, Elomaa O, Vaalamo M, et al. Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 2000;115(5);778-787.
12. Zhou YJ, Zhang J, Wang JH, et al. Expression of matrix metalloproteinase 2 and matrix metalloproteinase 9 in atherosclerotic plaques of diabetic patients and their significance. Chin J Modern Med 2005;15(8):1121-1124.
13. Whatling C, McPheat W, Hurt-Camejo E. Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling. Arterioscler Thromb Vasc Biol 2004;24(1): 10-11.
14. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92(8):827-839. (Pubitemid 36542523)
15. Irigoyen JP, Munoz-Canoves P, Montero L, et al. The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999;56(1-2):104-132 (Pubitemid 29471930)
16. Parra M, Lluis F, Caelles C, et al. The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (u-PA) by the alkylating agent MNNG. Blood 2000;96;(4):1415-1424.
17. Prager GW, Breuss JM, Steurer S, et al. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood 2004;103(3): 955-962.
18. Michaud-Levesque J, Rolland Y, Demeule M, et al. Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system. Biochim Biophys Acta 2005;1743 (3):243-253.
19. Irwin C, Synn A, Kraiss L, et al. Metalloproteinase expression in venous aneurysms. J Vasc Surg 2008;48(5):1278-1285.
20. Dewyer NA, Sood V, Lynch EM, et al. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. Surg Res 2007;142(2):357-363.
21. Bouzeghrane F, Zhang X, Gevry G, et al. Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice. J Vasc Surg 2008;48(6):1575-1584.